Global menu

Our global pages


Building longstanding and trusted relationships with our clients

  • United Kingdom
  • Global


    Eversheds Sutherland advises H2 Equity Partners on its acquisition of Optegra International Limited

    Eversheds Sutherland has advised longstanding client H2 Equity Partners, a leading Western European investment firm, on its acquisition of Optegra International Limited (Optegra), a pan-European eye care provider with operations in the UK, Poland and the Czech Republic.

    Optegra, which has nine dedicated eye hospitals and clinics across the UK, will work closely with H2 to deliver an ambitious growth strategy while ensuring it continues to provide excellent care and service to its patients.

    The Eversheds Sutherland team was led by Partners James Trevis and Lizzy Tindall on the corporate aspects of the deal, with support from Associates James Finney and Amy Bagni. Partner Colin Askew led on tax, while Partner Ronald Paterson and Associate Giulia Del Bianco advised on obtaining consent to the transaction from the Financial Conduct Authority.

    Lizzy Tindall commented:

    “We are delighted to have supported longstanding client, H2 Equity Partners, on the deal. Our international footprint was key to providing a successful service, due to Optegra having operations in Poland and the Czech Republic. Similarly, our health and life science credentials were fundamental to delivering the transaction, as was our advice on the regulatory aspects of the transaction and dealings with the FCA. We look forward to working with H2 again in the future and wish Optegra all the best with its continued growth plans.”

    Patrick Kalverboer, Managing Partner for H2 Equity Partners, commented:

    “We would like to thank Eversheds Sutherland for their support. The team’s technical and sector expertise allowed for a seamless service and a successful completion. We can now look forward to supporting Optegra in reaching its full potential in the next phase of its development.”

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back